Gd Midea Air-conditioning Equipment Co., Ltd.

Shenzhen Targetrx, Inc.

Midea Group Co., Ltd.

Guangdong Raynovent Biotech Co., Ltd.

Other

Globe Union Industrial Corporation

Guangdong Zhongsheng Pharmaceutical Co., Ltd

Remo Tech Co., Ltd.

Guangdong Xianqiang Pharmaceutical Co., Ltd

Zhiqiang Liu

Yihan Wang

Xianyou Mao

Xiaoxin Chen

Chaofeng Long

Zhiqiang Yang

Shuhui Chen

Zhuowei Liu

Liangrui Chen

Hongliang Yuan

Daijie Peng

Changlin Yan

Shupeng Chen

Weitao Xie

Liang Shen

Jian Li

Xing Liu

Yan Wang

Xiao Xun Zhang

Haiying He

Zhigan Jiang

Zhengxia Chen

Zhen Gong

Meibi Dai

Zeping Li

Shaoqing Lin

Zhiliang Yuan

Chengwu Liu

Ye Zhang

Zhenyou Tan

Zhiwei Cheng

Jiajun Huang

Guangqiang Zhou

Taisheng Liu

Xiao Zhang

Yuqi Ma

Hongsheng Zhou

Lixiang Liang

Leilei Gao

Yanjun Wang

Shaoqing Li

Wenjuan Li

A middle air duct support member and an air conditioner provided. The middle air duct support member has an annular first support portion and an annular second support portion arranged at an axial end of the first support portion. The second support portion and the first support portion are manufactured separately.

Middle air duct support member and air conditioner

Disclosed are sodium salts of pyrimidine derivatives, and a series of crystal forms thereof. The series of crystal forms exhibit a good druggability, such as stability, fluidity, compressibility, etc., and provide a variety of options of APIs for subsequent drug product development.

Dominant salt forms of pyrimidine derivatives, and crystal forms thereof

Provided are a substituted benzimidazole compound, and a composition comprising same and use thereof. The substituted benzimidazole compound is a compound represented by formula (I), or a pharmaceutically acceptable salt, prodrug, hydrate or solvate compound, polymorph, stereoisomer, or isotopic variation thereof. The compound can be used for treating and/or preventing related diseases caused by MEK, such as hyperproliferative diseases, pancreatitis, kidney diseases, blastocyte implantation, and diseases related to vasculogenesis or angiogenesis.

Substituted benzimidazole compound and composition comprising same

The present invention provides a diarylpyrazole compound, a composition comprising same, and a use thereof. The diarylpyrazole compound refers to the compound represented by a formula (I) or a tautomer, a stereoisomer, a prodrug, a crystalline form, a pharmaceutically acceptable salt thereof, a hydrate, or a solvent compound. The compound and the composition of the present invention can be used for treating BRAF kinase mutant proliferative diseases and have better pharmacokinetic properties.

Diarylpyrazole compound, composition comprising same, and use thereof

Smart network camera

An air conditioner indoor unit includes a housing, a collection device, and a lifting device. The housing includes a body and a top cover. A top of the body includes a fitting port and the top cover is disposed at the fitting port. The collection device is disposed at the top cover. The lifting device is coupled to the top cover and configured to drive the top cover to move between a storage position and a detection position that allows the collection device to collect external information outside the housing.

Air conditioner indoor unit with movable top cover

An N-benzenesulfonylbenzamide compound represented by the formula (I), or a crystal form, a prodrug, pharmaceutically acceptable salts, a stereoisomer, a solvate or a hydrate thereof, a pharmaceutical composition containing same, and a use thereof as a Bcl-2 protein inhibitor for preparing a medicament for treatment of leukemia or a cancer.

Benzenesulfonylbenazamide compound for inhibiting BCL-2 protein and composition and use thereof

The present invention relates to a pharmaceutical composition of a substituted pyridazinone compound and use thereof. The substituted pyridazinone compound is a compound as represented by formula (I), or a pharmaceutically acceptable salt, a prodrug, a hydrate or solvent compound, a crystalline form, and a stereoisomer or isotopic variant thereof. The compound is a THR-beta agonist which can be used for treating and/or preventing diseases regulated by thyroid hormone analogues. 

Substituted pyridazinone compound

An air duct having first to third air ducts, each of the first to third air ducts has a duct structure having a first end and a second end, the duct structure of the each of the first to third air ducts are separable from each other, a cross sectional area of the first end is greater than a cross sectional area of the second end, a plurality of cross sectional areas between the first end and the second end decrease progressively from the first end to the second end, and the first to third air ducts are communicated successively in a direction such that the second end of the duct structure of the third air duct is arranged closer to the second end of the duct structure of the first air duct and further from the first end of the duct structure of the first air duct.

Middle air duct of air conditioner and air conditioner

The present invention provides a salt form, a crystal form, and a preparation method of a compound as an FGFR4 inhibitor and medical uses thereof. 

Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof

An air conditioner includes a housing. The housing includes a panel including an opening. The air conditioner further includes an indicator light arranged at the opening, an air heat exchange duct and an air treatment duct arranged in the housing and not in communication with each other, an air heat exchange device arranged at the air heat exchange duct and configured to conduct heat exchange for air in the air heat exchange duct, and an air treatment device arranged at the air treatment duct and configured to conduct at least one of humidification or purification for air in the air treatment duct.

Air conditioner

A flush toilet is revealed. The flush toilet includes a bowl portion, a drain pipe, an inlet channel, a first outlet channel, a second outlet channel, and a jet channel. The first and second outlet channels are turned into different directions from diversion area of the inlet channel. The second outlet channel further includes a curved potion for changing the direction of water flow so that the direction of a second water flow out of the second outlet channel and along a shed portion of the bowl portion is consistent with the direction of a first water flow out of the first outlet channel and along the shed portion. Thus the first and second water flows are out almost synchronously throughout the bowl portion and combined to form a swirling flow which interacts with a third water flow from the jet channel to create a siphon effect for better waste removal.

Flush toilet

An air treatment device and an air conditioner indoor unit are provided. The air treatment device has an air outlet frame of a purification air duct. The air outlet frame has a ventilation hole and a cooperation hole. A water tank drawer is moveable on the air outlet frame and has two spaced-apart cooperation protrusions on a bottom wall thereof. A safety locking member of the air treatment device has a rotating shaft and a locking member. The rotating shaft is rotatable in the cooperation hole to switch the locking member between a locking position of the locking member and a movement-permitting position of the locking member. At the locking position, the locking member engages the cooperation protrusions to prevent the displacement of the cooperation protrusions. At the movement-permitting position, the locking member is located between the two cooperation protrusions to avoid engagement with the cooperation protrusions.

Air treatment device and air conditioner indoor unit having the same

The present invention discloses a class of pyrrolidine derivatives as PPAR agonist, and their use for the treatment of some diseases of PPAR receptor-associated pathways (such as nonalcoholic steatohepatitis and concurrent fibrosis, insulin resistance, primary biliary cholangitis, dyslipidemia, hyperlipidemia, hypercholesterolemia, atherosclerosis, hypertriglyceridemia, cardiovascular disease, obesity or the like). In particular, the present invention discloses a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof. 

Pyrrolidine derivatives as PPAR agonists

A method for implementing full cycle regeneration of a waste lead acid battery is provided. The method includes the following steps. Step (1): the waste lead acid battery is smashed and separated so as to obtain grid lead, diachylon, plastic and waste electrolyte. Step (2): the obtained diachylon after being dried is positioned into an airtight reactor for desulphurization and deoxidation, wherein lead sulfate and the lead dioxide both in the diachylon react to obtain lead monoxide (PbO) and sulfur trioxide (SO). Step (3): the obtained lead monoxide is reduced by solid phase electrolysis in a wet way so that the lead monoxide is reduced into sponge lead.

Method for implementing full cycle regeneration of waste lead acid batteries

Growing community of inventors

Guangdong, China

Zhiqiang Liu